Antifungal Medicated Bar

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Antifungal Medicated Bar
Generic name: TOLNAFTATE
Manufacturer: RoyceDerm LLC
Product type: HUMAN OTC DRUG
SPL set ID: 31305ed2-a0a0-6d4c-e063-6294a90a6ba5
SPL ID: 31305ed2-a0a1-6d4c-e063-6294a90a6ba5
Version: 1
Effective date: 2025-03-25
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:45:39

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Antifungal Medicated Bar	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		RoyceDerm LLC	openfda.manufacturer_name
ndc	package	85424-001-01	openfda.package_ndc
ndc	product	85424-001	openfda.product_ndc
ndc11	package	85424000101	derived:openfda.package_ndc
rxcui		1807715	openfda.rxcui
spl id		31305ed2-a0a1-6d4c-e063-6294a90a6ba5	id
spl set id		31305ed2-a0a0-6d4c-e063-6294a90a6ba5	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only on children under 2 years of age except under the advice and supervision of a doctor. avoid contact with the eyes. If contact occurs, rinse the eyes thoroughly with water. if condition worsens or does not improve after 4 weeks of regular use as directed. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.